期刊
CANCER LETTERS
卷 352, 期 1, 页码 54-58出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2013.08.029
关键词
Metastasis; Micrometastasis; Dormancy; Microenvironment
类别
资金
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Needham, MA, USA)
- Deutsche Forschungsgemeinschaft (DFG)
- Fred August and Adele Wolpers Charitable Fund (Clifton, NJ, USA)
- Pikovsky Fund (Jerusalem, Israel)
- James J. Leibman and Rita S. Leibman Endowment Fund for Cancer Research (New York, NY, USA)
Cancer cells that disseminate to metastatic sites may progress to frank metastasis or persist as dormant micrometastasis. Significant progress has been made in defining the genetic and phenotypic cancer-cell-autonomous determinants of metastasis and in the understanding of the cross-talk between metastasizing tumor cells and the metastatic microenvironment. However several questions remain open, in particular the identity of microenvironmental factors that keep micrometastatic cells in a state of dormancy and those that promote survival, proliferation and progression of such cells. Significantly more information is available on the latter factors than on microenvironmental cells and molecules that restrain micrometastasis. This mini-review summarizes findings suggesting that: The interactions between the metastatic microenvironment and cancer cells metastasizing to this microenvironment are unique to each metastatic microenvironment. cells or molecules in the metastatic microenvironment could act as double agents exerting pro- or anti-malignant functions. In the early phases of tumor progression, the interactions between cancer cells and the metastatic microenvironment are inhibitory whereas in later stages such interactions promote progression towards metastasis. In view of the above, it is not unlikely that metastases residing in different microenvironments may require individualized treatment modalities. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据